Mary C Beckerle sold $426K of Exelixis (EXEL)

Executed Feb 14 2025, disclosed Feb 19 2025, 5 days later.

Value, as filed

$426K

12,210 sh across 2 lots

Executed

Feb 14 2025

the trade date, as filed

Disclosed

Feb 19 2025

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MB Mary C Beckerle Director profile →

Mary C Beckerle (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Exelixis, Inc. (EXEL). The largest single filing was $1.0M of EXEL (24,622 sh across 2 lots, as filed), executed Nov 11 2025.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Mary C Beckerle in EXEL

EXELSALE Exelixis, Inc. $527K
9,812 sh × $53.66
Exec Aug 10
Filed Aug 12 · 7:34 PM ET EXELSALE Exelixis, Inc. $374K
7,712 sh × $48.45
Exec May 7
Filed May 8 · 5:30 PM ET EXELSALE Exelixis, Inc. $1.0M
24,622 sh across 2 lots
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET